Belite Bio (BLTE) Other Accumulated Expenses (2021 - 2025)

Belite Bio's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $599000.0 for Q4 2025.

• On a quarterly basis, Other Accumulated Expenses rose 4507.69% year-over-year to $599000.0 in Q4 2025; TTM through Dec 2025 was $599000.0, a 4507.69% increase from a year earlier, with the FY2025 full-year figure at $599000.0, up 4507.69% from the prior year.
• Other Accumulated Expenses advanced to $599000.0 in Q4 2025 per BLTE's latest filing, from $13000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $599000.0 in Q4 2025 and bottomed at $13000.0 in Q4 2024.
• The 5-year median for Other Accumulated Expenses is $95000.0 (2021), against an average of $177800.0.
• Across the five-year window, Other Accumulated Expenses tumbled 87.96% in 2024 and surged 4507.69% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $95000.0 in 2021, then decreased by 22.11% to $74000.0 in 2022, then jumped by 45.95% to $108000.0 in 2023, then tumbled by 87.96% to $13000.0 in 2024, then jumped by 4507.69% to $599000.0 in 2025.
• Per Business Quant, the three latest BLTE Other Accumulated Expenses figures stand at $599000.0 (Q4 2025), $13000.0 (Q4 2024), and $108000.0 (Q4 2023).